Since you follow the space and are aware of the alxn results you also know that the peak ck-mb of 100ng/ml is the most appropriate endpoint and medicure's data shows that it reduces the risk of MI and death when that marker is used.
No 100ng/ml is not the most appropriate endpoint. Can you please explain how you come to this conclusion?